Warby Parker Financial Ratios
NYSE: WRBYHealth CareOphthalmic GoodsUSD
25.30+0.35 (+1.40%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Warby Parker ratio analysis
Warby Parker earned a net margin of 0.2% in FY 2025, up from -2.6% a year earlier. Gross margin was 54.0% compared with a median of 57.9% over the prior 6 years. Return on equity reached 0.4%, meaning Warby Parker generated 0.00 dollars of profit for every dollar of shareholders' equity.
Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
Warby Parker financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| P/E ratio (at fiscal year end) | 2,262.00 | — | — | — | — | — | — |
| Price / sales | 3.18 | 4.13 | 2.47 | 2.59 | 6.13 | — | — |
| Price / book | 7.55 | 9.37 | 5.48 | 5.41 | 11.60 | — | — |
| Gross margin | 54.0% | 55.3% | 54.5% | 57.0% | 58.8% | 58.9% | 60.2% |
| Operating margin | -0.6% | -3.9% | -10.7% | -18.6% | -26.6% | -14.1% | -0.4% |
| Net margin | 0.2% | -2.6% | -9.4% | -18.5% | -26.7% | -14.2% | 0.0% |
| Free cash flow margin | 5.0% | 4.5% | 1.1% | -8.3% | -14.9% | 3.2% | -3.0% |
| Return on equity (ROE) | 0.4% | -6.0% | -20.9% | -38.5% | -50.4% | — | — |
| Return on assets (ROA) | 0.2% | -3.0% | -10.9% | -19.4% | -32.7% | -12.6% | — |
| Current ratio | 2.35 | 2.50 | 2.35 | 2.27 | 2.78 | 3.42 | — |
| Revenue growth | 13.0% | 15.2% | 12.0% | 10.6% | 37.4% | 6.3% | — |